WuXi Biologics hatches new baby with ADC drug unit IPO
药明生物分拆药明合联 “药明系”港股再冲刺

The drug outsourcing services company is spinning off its WuXi XDC unit, seizing on investor enthusiasm for a new generation of highly targeted ADC drugs
乘着市场对ADC药物的热度，药明生物通过分拆药明合联在资本市场吸金